Pharmacy and neighborhood-level variation in cash price of diabetes medications in the United States.

ABSTRACT:

Background

Diabetes medications place significant financial burden on patients but less is known about factors affecting cost variation.

Objective

To examine pharmacy and neighborhood factors associated with cost variation for diabetes drugs in the US.

Research design, subjects and measures

We used all-payer US pharmacy data from 45,874 chain and independent pharmacies reflecting 7,073,909 deidentified claims. We divided diabetes drugs into insulins, non-insulin generic medications, and brand name medications. Generalized linear models, stratified by pharmacy type, identified pharmacy and neighborhood factors associated with higher or lower cash price-per-unit (PPU) for each set of drugs.

Results

Cash PPU was highest for brand name therapies ($149.4±203.2), fol

SUBMITTER: Warraich HJ 

PROVIDER: S-EPMC10703254 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature